Advertisement
Organisation › Details
6 Dimensions Capital (Group)
6 Dimensions Capital is a leading healthcare focused investment firm with an in-depth focus and extensive coverage across China and the United States. It consists of a team of about 40 investment and operation professionals with offices in Shanghai, Hong Kong, Boston, and Palo Alto. The firm currently has US$1.6 billion assets under management through 4 US dollar-denominated and 3 RMB-denominated funds and has cultivated a portfolio of more than 80 companies. *
Start | 2017-05-18 merged | |
Predecessor | WuXi Heatlhcare Ventures (WuXi Ventures) | |
Industry | venture capital | |
Industry 2 | LIFE SCIENCES | |
Person | Chen, Leon (6 Dimensions Capital 201705– CEO before Frontline BioVentures + Fidelit Growth Partners Asia) | |
Person 2 | Li, Ge (WuXi AppTec CEO + Founder) | |
Region | Shanghai | |
Country | China | |
Street | 999 Huanke Road Pudong New District, Block 17 | |
City | 201210 Shanghai | |
Tel | +86-21-6839-1989 | |
Address record changed: 2021-02-21 | ||
Basic data | Employees | B: 11 to 50 (2017-05-18) |
Currency | USD | |
Annual sales | 1,500,000,000 (assets, managed (2021) 2021-02-21) | |
* Document for »About Section«: Kymera Therapeutics Inc.. (11/13/18). "Press Release: Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology". Cambridge, MA. | ||
Record changed: 2021-10-07 |
Advertisement
More documents for 6 Dimensions Capital (Group)
- [1] Kymera Therapeutics Inc.. (11/13/18). "Press Release: Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology". Cambridge, MA....
- [2] FogPharma (Fog Pharmaceuticals Inc.). (5/16/18). "Press Release: FogPharma Secures $66 Million Series B Financing". Boston, MA....
- [3] LifeMine Therapeutics Inc.. (9/18/17). "Press Release: LifeMine Therapeutics Launches with $55 Million Series A Financing". Boston, MA....
- [4] WuXi Healthcare Ventures. (5/18/17). "Press Release: WuXi Healthcare Ventures and Frontline BioVentures Join Forces to Form 6 Dimensions Capital, a Leading China and US Focused Investment Group Specializing in Healthcare and Life Sciences". Shanghai, et...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top